Drugs / PR013
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03368339 Comparator | Dec 2017 → Jan 2018 | eye allergy | Realm Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PR013 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03368339 ↗ |
| Route | Topical | “topical Ophthalmic Drops (0.045%)” NCT03368339 ↗ |